Most Recent
The wide spectrum of columns available makes selecting this most important component of an LC system extremely difficult. Column choices span normal phase, reverse phase, size exclusion, ion exchange, hydrophobic interaction, & affinity chromatography. One is hard-pressed to find a more innovative, selfreflective instrument market.
The editors of Lab Manager Magazine hope to simplify your decision-making by bringing together a panel of technical experts from various companies to discuss innovations in HPLC/UHPLC columns.
Liquid chromatographers have a wealth of choices when it comes to columns and systems: HILIC, chiral, mixed mode, supercritical fluid (SCF), normal phase, ion exchange. But the pharmaceutical industry’s influence on LC products is such that reversephase (predominantly C18 and C8) remains the most popular chromatography mode “by a large margin,” says Denis Boudriau, product specialist at SiliCycle (Quebec, Canada).
Kinetex®

-
Meets researchers’ need to improve results and increase productivity without large capital expenditures
-
Delivers significant improvements in speed and separation efficiency over traditional 3- and 5-micron columns
-
Enables chromatographers to get performance comparable to sub-2-micron columns without investing in UHPLC systems
Phenomemex
www.phenomenex.com
Accucore™ 150-C18 & 150-C4

-
Designed to improve protein and peptide assay robustness
-
Enhance peak capacity and run times at moderate operating pressures
-
150-C18 has been further optimized for biomolecules and protein digests
Thermo Fisher Scientific
www.thermoscientific.com
Column technology has been a rich area for HPLC R&D. As reasonably expensive consumables, columns are a significant factor in LC operating costs and performance—
in other words, key value drivers. Superficially porous particles (SPPs) represent a
INTRODUCTION
Reaction screening and purification are essential steps in small molecule
pharmaceutical discovery labs. Cleaner samples for subsequent synthesis
can reduce reaction by-products and facilitate the critical final purification
of
Phenomenex Inc.introduces new SecurityGuard™ ULTRA offerings to protect widepore (=200 Å) UHPLC columns typically used in the analysis of biomolecules.
The origins of high-performance liquid chromatography (HPLC) date back to the invention of chromatography in the early 20th century, then to partition and paper chromatography in the 1940s, and finally to the introduction of liquid chromatography in
Agilent Technologies Inc. recently announced it has expanded its family of sub-2 µm particle 300 Angstrom pore columns for reversed-phase liquid chromatography with rapid-resolution, high-definition ZORBAX 300SB-C3 and 300-Diphenyl 1.8 µm columns.
Most Recent
Column technology has been a rich area for HPLC R&D. As reasonably expensive consumables, columns are a significant factor in LC operating costs and performance—
in other words, key value drivers. Superficially porous particles (SPPs) represent a
Lab Manager Magazine's online surveys help improve the purchasing process and provide you with greater confidence in your final purchasing decision. Please take 3 minutes and complete our survey.
Most Recent
Kinetex®

-
Meets researchers’ need to improve results and increase productivity without large capital expenditures
-
Delivers significant improvements in speed and separation efficiency over traditional 3- and 5-micron columns
-
Enables chromatographers to get performance comparable to sub-2-micron columns without investing in UHPLC systems
Phenomemex
www.phenomenex.com
Accucore™ 150-C18 & 150-C4

-
Designed to improve protein and peptide assay robustness
-
Enhance peak capacity and run times at moderate operating pressures
-
150-C18 has been further optimized for biomolecules and protein digests
Thermo Fisher Scientific
www.thermoscientific.com
Most Recent
The editors of Lab Manager Magazine hope to simplify your decision-making by bringing together a panel of technical experts from various companies to discuss innovations in HPLC/UHPLC columns.
Most Recent
INTRODUCTION
Reaction screening and purification are essential steps in small molecule
pharmaceutical discovery labs. Cleaner samples for subsequent synthesis
can reduce reaction by-products and facilitate the critical final purification
of
Thermo Fisher Scientific Inc. is pleased to announce a new application demonstrating the separation of common inorganic anions and cations in municipal drinking water samples.